iNtRON Biotechnology, Inc. (KOSDAQ:048530)
South Korea · Delayed Price · Currency is KRW 4,060.00
-20.00 (-0.49%)
Apr 1, 2026, 3:30 PM KST
iNtRON Biotechnology Market Cap
iNtRON Biotechnology has a market cap or net worth of 125.07 billion as of April 1, 2026. Its market cap has decreased by -2.22% in one year.
Market Cap
125.07B
Enterprise Value
86.65B
Revenue
5.74B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,060.00
Market Cap Chart
Since January 26, 2011, iNtRON Biotechnology's market cap has increased from 95.30B to 125.07B, an increase of 31.24%. That is a compound annual growth rate of 1.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 125.07B | 21.73% |
| Dec 30, 2025 | 102.75B | -44.03% |
| Dec 30, 2024 | 183.56B | -37.01% |
| Dec 28, 2023 | 291.42B | 7.98% |
| Dec 29, 2022 | 269.88B | -61.99% |
| Dec 30, 2021 | 710.00B | -22.41% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genexine | 210.57B |
| MedPacto | 191.94B |
| Vaxcell-Bio Therapeutics | 177.45B |
| Macrogen | 172.38B |
| ENCell | 161.62B |
| Amicogen | 114.49B |
| CG Invites | 114.03B |
| IMB Dx | 90.84B |